U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
OMNINET MEDIA.COM, INC.
(Name of Small Business Issuer)
Date of Report (Date of earliest event reported) January 15, 2001
Nevada 000-28935 880398783
(State or Other Commission (I.R.S. Employer
Jurisdiction of File No. Identification
Incorporation or Number)
8615 E. Florence, Suite 210, Downey, CA 89024
(Address of Principal Executive Offices) (Zip Code)
(Registrant's Telephone Number)
Item 1. Changes in Control of Registrant
Effective January 15, 2001 the Board of Directors of OmniNet Media.com, Inc.
accepted the resignations of Michael A. Knox as President and as a Director of
the corporation. At the same time, the Board elected Don A. Steffens as a
Director to fulfill the unexpired term of Mr. Knox, and as President of the
Mr. Steffens, born on April 25, 1947 previously served as President of
OmniNet. He has held key management positions which have provided him with
Twenty-Five years of experience as President/CEO, Chief Financial Officer and
Chief Operational Officer with several public and private corporation. His
career has been involved with commercialization of a wide range of technology
driven products. Over the years he has developed valuable contracts with high
profile corporations for partnering of strategic marketing alliances,
manufacturing and distribution to launch new products into the market place,
including software applications for the banking industry, in-store advertising
concepts for retail chain stores and product distribution of drug and dietary
supplements. From 1983 Mr. Steffens successfully negotiated international
licensing and distribution agreements for software and pharmaceutical products
developed and manufactured by three corporations co-founded by Mr. Steffens,
including Bio-sphere Technology, Inc., Marina Systems International, Inc. and
Southwest Medical Research Foundation, Inc.
Mr. Steffens' business history by date, year and positions since August of
1985 is as follows
August 1985-October 1990: Saudi-Japan Economic Culture Cooperation Committee,
Tokyo, Japan. During this period Mr. Steffans reported to the Chairman of the
Board, Mr. Isao Ishikawa, as his U.S. representative to assist his efforts in
arranging financing, the purchase of various real estate properties and
funding large projects in the U.S. and Europe.
October 1990-June 1996: Foundation for Applied Research Technology, Inc., La
Mirada California. Mr. Steffens was Vice President/COO/CFO and Director for
this non-profit organization founded in 1979 to fund new technologies for the
treatment of cardiovascular diseases. He acted as fund raiser and site
location manager for clinical trials for this employer.
May 1992-June 1998: Southwest Medical Research Foundation, Inc., Las Vegas,
Nevada. Mr. Steffens was co-founder with Jackie R. See, MD and acted as
COO/CFO and Director. He formed and arranged investor financing to develop
manufacturing protocols and procedures to produce micro-encapsulated
(Liposomal) drugs, utilizing the company's proprietary technology. He managed
all investor fund raising efforts, set up manufacturing laboratory site, and
completed all phases of the production of drugs for clinical trial.
February 1992-June 1998: Bio-Sphere Technology, Inc., Las Vegas, Nevada and
Irvine, California. He was cou-founder of this bio-pharmaceutical company
with Jackie R. See, M.D. and acted as CFO/COO, Secretary and Director. The
company developed liposomal technology to deliver various drugs for the
treatment of erectile dysfunction, cholesteroal, oral vaccines and
restinosis. Managed the day to day business activities, including arranging
investor financing, manufacturing, FDA compliance, licensing agreements and
co-authored and filed patent applications and PCT's.
December 1996-November 1997: Harvard Scientific Corp., Irvine, California and
Reno, Nevada. He was President, CEO/CFO and Director of this publicly held
company which, at one time was a wholly-owned subsidiary of Bio-Sphere
Technology, Inc. This Company developed and patented a drug for the treatment
of erectile dysfunction and is in the process of completing clinical trials.
Mr. Steffens was responsible for investor relations, arranging financing, and
setting up CRO's and manufacturing partners. Through is efforts this Company
received a $15 million debenture to finance its ongoing clinical trials.
May 1991-March 2000. Natural Right Technologies, Inc., Downey, California.
Mr. Steffens was President and Director of this closely-held corporation that
manufactured and marketed dietary food supplements to European and Canadian
distributors. The company terminated all contracts in March 2000.
Item 2. Acquisition or Disposition of Assets.
In its Form 10KSB/A filed on November 22, 2000 OmniNet reported that it was in
the business, through its subsidiary U.S./Ace Securities Lamninates, of
distributing laminated safety glass products, and that it intended to do so by
licensing dealers to sell the products and, in notes to the included financial
statements, noted that U.S./Ace was in default of payments due under its
licensing agreement with Clear Defense, Inc. of Virginia. That licensing
agreement has now been forfeited for non-payment and the office of U.S./Ace
has been closed. U.S./Ace Security Laminates is no longer conducting active
Item 3. Bankruptcy or Receivership.
Item 4. Changes in Registrant's Certifying Accountant.
Item 5. Other Events.
OmniNet Media.com, Inc. previously maintained its principle place of business
at 5580 LaJolla Blvd., Ste 71, LaJolla, CA 92037. That office has been closed
and the Company is maintaining a temporary office at 8615 E. Florence, Suite
210, Downey, CA 9024. However, negotiations are presently being conducted for
the purpose of leasing new office space at the World Trade Center in Long
Beach, California. Management expects to have a lease agreement in place
regarding this space within ten days.
Item 6. Resignation of Registrant's Directors.
As indicate in Item 1 hereof, Michael A. Knox resigned as a Director of the
registrant on January 15, 2001. His resignation did not result from any
disagreement with the registrant on any matter relating to the registrant's
operations, policies or practices, and Mr. Knox has addressed no letter or
other document to the Company or its Directors describing any such
disagreement. His resignation was solely for personal reasons.
Item 7. Financial Statements and Exhibits.
Item 8. Change in Fiscal Year.
Item 9. Sale of Equity Securities Pursuant to Regulation S.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
OMNINET MEDIA.COM, INC.
By:/s/ James A. Graves
James A. Graves, Secretary